COVID-19 is an emerging, rapidly evolving situation.
ORWH is now accepting applications for a Challenge Prize competition aimed at increasing gender diversity among faculty members at colleges and universities and removing barriers to the uptake of systemic institutional approaches for transformative change.
Top Stories
The NIH Maternal Morbidity and Mortality (MMM) web portal collects information about how women in the United States, particularly Black women, experience much higher rates of pregnancy-related injury, illness, and fatality than women in peer nations.
The Office of Disease Prevention and Health Promotion (ODPHP) of the U.S. Department of Health and Human Services (HHS) recently released Healthy People 2030, a plan that sets data-driven objectives for addressing the Nation’s most critical public health priorities.
ORWH Associate Director for Science Policy, Planning, and Analysis Samia Noursi, Ph.D.; ORWH Director Janine A. Clayton, M.D.; and colleagues recently published “The Intersection of "Maternal Morbidity and Mortality and Intimate Partner Violence in the United States."
On September 2, 2020, NIH will virtually host the Inclusion Across the Lifespan-II Workshop: Implementation and Future Directions.
On Tuesday, September 1, 2020, at 1:00 p.m. (Eastern Time), ORWH will host an hour-long webinar titled “Incorporating a Sex-and-Gender Lens from Bench to Bedside: Neurology,” featuring Farida Sohrabji, Ph.D., of Texas A&M College of Medicine.
On August 5, 2020, ORWH Director Janine A. Clayton, M.D., and ORWH Associate Director for Careers Xenia Tigno, Ph.D., hosted a Facebook Live panel discussion and Q&A session about leadership among women in STEMM.
As recent months have demonstrated, stress is unavoidable. Now more than ever, it’s important to understand stress and how we can manage it.
On July 22, 2020, ORWH hosted an online panel discussion titled “Improving Chronic Disease Outcomes Through Approaches that Address Social Determinants of Health.”
NIH recently released the NIH-Wide Strategic Plan for COVID-19 Research. The strategic plan describes five priorities for accelerating the development of therapeutic interventions, vaccines, and diagnostics.